Prospera Financial Services’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $994K | Buy |
9,251
+1,348
| +17% | +$145K | 0.02% | 657 |
|
|
2025
Q1 | $797K | Buy |
7,903
+1,092
| +16% | +$110K | 0.02% | 626 |
|
|
2024
Q4 | $608K | Buy |
6,811
+30
| +0.4% | +$2.68K | 0.01% | 680 |
|
|
2024
Q3 | $568K | Sell |
6,781
-329
| -5% | -$27.6K | 0.01% | 681 |
|
|
2024
Q2 | $548K | Buy |
7,110
+299
| +4% | +$23K | 0.02% | 681 |
|
|
2024
Q1 | $466K | Buy |
6,811
+436
| +7% | +$29.9K | 0.01% | 729 |
|
|
2023
Q4 | $369K | Sell |
6,375
-781
| -11% | -$45.2K | 0.01% | 762 |
|
|
2023
Q3 | $378K | Buy |
7,156
+463
| +7% | +$24.4K | 0.01% | 713 |
|
|
2023
Q2 | $362K | Sell |
6,693
-131
| -2% | -$7.09K | 0.01% | 715 |
|
|
2023
Q1 | $341K | Buy |
6,824
+245
| +4% | +$12.3K | 0.01% | 743 |
|
|
2022
Q4 | $304K | Sell |
6,579
-261
| -4% | -$12.1K | 0.02% | 699 |
|
|
2022
Q3 | $266K | Buy |
6,840
+5,244
| +329% | +$204K | 0.01% | 687 |
|
|
2022
Q2 | $59K | Sell |
1,596
-4,876
| -75% | -$180K | ﹤0.01% | 1002 |
|
|
2022
Q1 | $287K | Buy |
6,472
+691
| +12% | +$30.6K | 0.01% | 756 |
|
|
2021
Q4 | $246K | Sell |
5,781
-3,493
| -38% | -$149K | 0.01% | 767 |
|
|
2021
Q3 | $402K | Buy |
9,274
+500
| +6% | +$21.7K | 0.02% | 587 |
|
|
2021
Q2 | $375K | Buy |
8,774
+1
| +0% | +$43 | 0.02% | 599 |
|
|
2021
Q1 | $339K | Sell |
8,773
-47
| -0.5% | -$1.82K | 0.02% | 587 |
|
|
2020
Q4 | $317K | Buy |
8,820
+4,738
| +116% | +$170K | 0.02% | 525 |
|
|
2020
Q3 | $156K | Sell |
4,082
-4,389
| -52% | -$168K | 0.06% | 291 |
|
|
2020
Q2 | $297K | Buy |
+8,471
| New | +$297K | 0.03% | 447 |
|